RAPAGEN
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Oct 2018)
What this means for you
This application is over — abandoned 01 Oct 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86528633
- Mark type
- Stylized text
- Filed
- 09 Feb 2015
- Published for opposition
- 30 Jun 2015
- Abandoned
- 01 Oct 2018
- Attorney of record
- Michael Bamberger
Goods and services
- Class 005 — Pharmaceuticals: A combination drug product, namely, a formulation of sirolimus incorporated within a collagen membrane, which, as an implantable drug carrier, enables local delivery of sirolimus to the vascular wall
Owner
- Vascular Therapies, Inc., Cresskill, NJ, US
- Vascular Therapies, Inc., Cresskill, NJ, US
Prosecution history
- 01 Oct 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 01 Oct 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2018 — SOU EXTENSION 5 GRANTED
- 23 Feb 2018 — SOU EXTENSION 5 FILED
- 26 Feb 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Feb 2018 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2017 — SOU EXTENSION 4 GRANTED
- 17 Aug 2017 — SOU EXTENSION 4 FILED
- 17 Aug 2017 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2017 — SOU EXTENSION 3 GRANTED
- 09 Feb 2017 — SOU EXTENSION 3 FILED
- 09 Feb 2017 — SOU TEAS EXTENSION RECEIVED